What IKA Recommends for Pediatric Keratoconus Screening and Management

Updated

The International Keratoconus Academy (IKA) recommends routine risk assessment for children and adolescents, advanced corneal imaging (including Scheimpflug tomography and OCT) for those at increased risk, and prompt corneal cross-linking once early disease is identified—rather than waiting for documented progression. This approach applies to pediatric patients, in whom keratoconus is frequently more aggressive and progresses faster than in adults.

Why children get a different approach

IKA frames pediatric keratoconus as a time-sensitive problem. Because the disease can advance rapidly during childhood and adolescence, the Academy argues that the historical practice of observing patients until progression is documented risks irreversible structural damage and vision loss. Its stated priority is a shift toward early diagnosis and intervention, with the goal of preserving vision during the years of visual development and reducing the long-term need for corneal transplantation.

What the screening recommendation involves

IKA's pediatric initiative calls for two things to be built into the evaluation of children and adolescents at increased risk for ectatic disease:

  • Routine risk assessment — identifying which young patients warrant closer corneal evaluation in the first place.
  • Advanced corneal imaging — specifically naming Scheimpflug corneal tomography and Optical Coherence Tomography (OCT) as technologies to incorporate into that evaluation.

The Academy's research pages include prevalence work using Scheimpflug corneal tomography metrics in a pediatric population (Harthan et al.), which underpins its emphasis on imaging-based detection in children.

What the management recommendation involves

When early disease is identified, IKA promotes evidence-based treatment algorithms that incorporate corneal cross-linking at the earliest appropriate stage. In practical terms, the recommended sequence is:

  1. Assess risk in the pediatric patient.
  2. Image the cornea with tomography (and OCT where indicated).
  3. If early ectasia is detected, move to cross-linking at the earliest appropriate point rather than monitoring for progression.
  4. Continue care aimed at preserving vision through visual development.

Where to verify or follow the guidance

IKA states that it translates emerging scientific evidence into practical clinical recommendations and builds consensus on diagnosis and management of corneal ectatic disease. Its channels for this include scientific meetings, continuing education, webinars, online educational resources, peer-reviewed publications, and collaborative clinical research. The site lists its 4th Annual IKA Keratoconus Symposium (Saturday, December 12, 2026, Dallas, Texas) with the address ikasymposium.com for program details.

Limits to keep in mind

The available IKA material describes recommendations and priorities; it does not provide a numerical risk-scoring tool, specific imaging cutoffs, or a cross-linking protocol on the pages summarized here. For those specifics, the peer-reviewed publications and symposium programming referenced by the Academy are the appropriate sources, and treatment decisions for an individual child belong with an eye care professional experienced in corneal ectatic disease.